Syngene International   Report issue

For profit Phase 1
Founded: Bangalore India (1994)

Organization Overview

First Clinical Trial
2018
NCT03509545
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Alternative names

Syngene International | Syngene International Limited

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Body Weight (Phase 1)

Body Weight Changes (Phase 1)

Premature Birth (Phase 1)

Overview

  • Highest Phase: Phase 1
  • # of Trials: 3
  • # of Trial APIs: 5